Senate Bill Expands FDA's OTC Manufacturing Oversight
This article was originally published in The Tan Sheet
Executive Summary
Legislation introduced in the Senate to give FDA mandatory recall authority for all drugs would bar the agency from considering a drug's prescription status when assessing risk to prioritize inspections